Novartis heart failure drug effective across patient groups Reuters UK AMSTERDAM (Reuters) - An experimental drug from Novartis to treat heart failure proved equally effective regardless of the age of patients or whether they had other medical problems, clinical trial results presented on Monday showed. The drug ... Novartis' serelaxin (RLX030) improved symptoms and mortality across multiple ... Novartis: RLX030 Improved Symptoms, Mortality In Heart Patients Novartis: RLX030 Found Effective Across Multiple Subgroups Of Heart Patients |
